Please login to the form below

Not currently logged in
Email:
Password:

FCA

This page shows the latest FCA news and features for those working in and with pharma, biotech and healthcare.

UK financial authority confirms Woodford probe

UK financial authority confirms Woodford probe

The Financial Conduct Authority (FCA) is looking into the factors that led to a block on money coming in or going out of the Woodford Equity Income Fund (WEIF) on 3 ... The FCA confirms the investigation is ongoing but won’t comment any further, and

Latest news

  • Novartis' Ilaris launched in UK

    CAPS includes three auto-inflammatory disorders of increasing severity: familial cold auto-inflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), and neonatal-onset multisystem inflammatory disease (NOMID).

  • FDA Approves drug for rare disease

    Arcalyst, which is manufactured by Regeneron Pharmaceuticals, was approved for the long-term treatment of Cryopyrin-associated periodic syndromes (CAPS) disorders such as familial cold auto-inflammatory syndrome (FCAS) and

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Rise of generics will curb France’s pharma growth Rise of generics will curb France’s pharma growth

    Sanofi, Schering-Plough (wholly owned by MSD since 2009) and Janssen are among the companies the French Competition Authority (FCA) has launched enquiries into for this over the last few years. ... The government and the FCA contend, however, that

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...

Infographics